Introduction {#sec0005}
============

Dementia is a leading cause of disability and dependence in older people worldwide \[[@ref001]\]. Features of dementia include a progressive decline in cognition, including deficits to memory as well aslanguage or executive function, and a subsequent loss of social or occupational function, including activities of daily living (ADL) \[[@ref002]\]. Furthermore, dementia is frequently accompanied by deficits to balance and gait \[[@ref003]\], which appear especially affected in certain types of dementia such as vascular dementia, dementia with Lewy bodies, or Parkinson's disease dementia compared with Alzheimer's disease (AD) \[[@ref004]\]. Gait and balance dysfunction have been linked to cognitive function, in particular executive function \[[@ref005]\]. Beside cognitive impairment, gait and balance deficits are associated with dependence in ADLs. Pharmacological treatment has been shown to benefit cognitive function and dependence in ADLs in people with AD \[[@ref006]\], but side effects are common and the usefulness in people with vascular dementia remains less certain \[[@ref007]\]. Further evaluation of complimentary disease modifying treatment to optimize cognitive function and preserve independence in people with dementia is imperative, given the considerable burden of dementia for the individual, their family, and society.

About a third of all AD cases may be attributed to potentially modifiable risk factors, predominantly physical inactivity \[[@ref008]\], which implies that the disease can be prevented. Various potential mechanisms have been explored. Human and animal studies suggest that physical exercise can stimulate improvement in cerebrovascular function, perfusion, and neuroplasticity in the brain, which may prevent the progressive loss of cognitive function associated with aging and disorders such as dementia \[[@ref009]\]. However, causal effects of physical exercise on cognitive function remain equivocal in older people \[[@ref011]\]. Furthermore, although promising evidence suggests that exercise affects dependence in ADLs in people with dementia \[[@ref013]\], randomized controlled trials investigating effects of exercise on cognition show inconsistent results \[[@ref013]\]. Positive exercise effects on cognitive function seem apparent only in studies that are small or lack blinded testers \[[@ref017]\] or comparable attention control groups \[[@ref017]\]. To explore the effects of exercise as a single intervention in people with dementia, the additional attention brought by the intervention may need to be matched in the control group because amount of attention has been shown to influence cognitive function in this population \[[@ref023]\], which is often characterized by limited social interaction \[[@ref024]\]. In addition, no study has compared the effects of exercise between dementia types.

The aim of this study was to investigate effects of a high-intensity functional exercise program on cognitive function in people with dementia who had mild to severe cognitive impairment, and whether the effects were moderated by cognitive level at baseline, sex, or type of dementia.

Material and methods {#sec0010}
====================

This study was part of the Umeå Dementia and Exercise Study (UMDEX), a cluster-randomized controlled trial conducted in Umeå, Sweden, and has been described in detail elsewhere \[[@ref014]\]. The study was set in 16 nursing homes, which comprised general and dementia specialized units, all with private rooms and staff on hand, as well as units with private apartments with access to on-site nursing and care staff. The study protocol (ISRCTN31767087) is published on the ISRCTN registry.

Participants {#sec0015}
------------

Enrollment and baseline testing were performed in August through September 2011. Criteria for inclusion were a Mini-Mental State Examination (MMSE) score≥10 \[[@ref028]\], a dementia diagnosis \[[@ref002]\], age≥65 y, dependent on assistance in≥1 personal activity of daily living according to the Katz Index \[[@ref029]\], ability to stand up from a chair with armrests with assistance from≤1 person, physician's approval, and ability to hear and understand spoken Swedish sufficiently to participate in assessments. All individuals included in the study gave informed oral consent to participation, which was confirmed by their next of kin. A total of 864 nursing home residents were screened. Age (*p* = 0.189) and MMSE score (*p* = 0.713) did not differ between participants included and those who declined participation (*n* = 55; [Fig. 1](#jad-60-jad170014-g001){ref-type="fig"}). A larger proportion of men than women declined participation (34% versus 18%; *p* = 0.008). Baseline characteristics of the 186 participants are presented in [Table 1](#jad-60-jad170014-t001){ref-type="table"}.

![Flow of participants through the study. ADLs, Activities of Daily Living; MMSE, Mini-Mental State Examination.](jad-60-jad170014-g001){#jad-60-jad170014-g001}

###### 

Baseline characteristics

  Characteristic                                                Total       Exercise       Control
  --------------------------------------------------------- ------------- ------------- -------------
  Age                                                        85.1 (7.1)    84.4 (6.2)    85.9 (7.8)
  Female, *n* (%)                                            141 (75.8)     70 (75.3)     71 (76.3)
  Dementia type, *n* (%)                                                                
    Vascular dementia                                         77 (41.4)     36 (38.7)     41 (44.1)
    Alzheimer's disease                                       67 (36.0)     34 (36.6)     33 (35.5)
    Other                                                     27 (14.5)     15 (16.1)     12 (12.9)
    Mixed Alzheimer's disease/Vascular dementia               15 (8.1)       8 (8.6)       7 (7.5)
  Diagnoses and medical conditions, *n* (%)                                             
    Depressive disorders                                     107 (57.5)     53 (57.0)     54 (58.1)
    Delirium previous week                                   102 (54.8)     48 (51.6)     54 (58.1)
    Previous Stroke                                           57 (30.6)     33 (35.5)     24 (25.8)
    Heart failure                                             56 (30.1)     24 (25.8)     32 (34.4)
    Previous hip fracture                                     53 (28.5)     28 (30.1)     25 (26.9)
    Angina pectoris                                           49 (26.3)     21 (22.6)     28 (30.1)
    Diabetes mellitus                                         29 (15.6)     18 (19.4)     11 (11.8)
  Prescription medication, *n* (%)                                                      
    Analgesics                                               112 (60.2)     55 (59.1)     57 (61.3)
    Antidepressants                                          102 (54.8)     58 (62.4)     44 (47.3)
    Diuretics                                                 88 (47.3)     41 (44.1)     47 (50.5)
    Vitamin D-Calcium supplement                              60 (32.3)     32 (34.4)     28 (30.1)
    Cholinesterase inhibitor                                  40 (21.5)     25 (26.9)     15 (16.1)
    Benzodiazepines                                           40 (21.5)     19 (20.4)     21 (22.6)
    Neuroleptics                                              31 (16.7)     11 (11.8)     20 (21.5)
    Memantine                                                 12 (6.5)       7 (7.5)       5 (5.4)
    Number of drugs, mean (SD)                                8.3 (3.8)     8.4 (4.0)     8.2 (3.7)
  Assessments                                                                           
    Mobility Device, *n* (%)                                 145 (78.0)     76 (81.7)     69 (74.2)
    Mini Nutritional Assessment (0--30), *n* = 185^a^        21.1 (2.7)    21.3 (2.8)    20.9 (2.6)
    Geriatric Depression Scale-15 (0--15), *n* = 183^b,c^     3.8 (3.2)     4.0 (3.4)     3.6 (2.9)
    Neuropsychiatric Inventory (0--144)^b^                   14.8 (14.2)   15.2 (15.8)   14.4 (12.6)
    Vision impairment, *n* (%)^d^                             26 (14.0)     10 (10.8)     16 (17.2)
    Hearing impairment, *n* (%)^e^                            52 (28.0)     20 (21.5)     32 (34.4)
    Self-reported health; good, very good, or excellent,     119 (64.0)     60 (64.5)     59 (63.4)
     *n* (%)                                                                            
    Barthel ADL Index (0--20)^a^                             10.9 (4.4)    10.7 (4.5)    11.0 (4.4)
    Berg Balance Scale (0--56)^a^                            28.9 (14.5)   28.6 (14.3)   29.3 (14.7)
  Outcome measures                                                                      
    Mini-Mental State Examination (0--30)^a^                 14.9 (3.5)    15.4 (3.4)    14.4 (3.5)
    Alzheimer's disease assessment scale -- Cognitive        31.6 (10.8)   31.8 (11.4)   31.3 (10.3)
   section (0--70), *n* = 183^b^                                                        
    Verbal fluency, *n* = 182^a^                              6.4 (3.8)     6.8 (4.1)     5.9 (3.5)

Values are mean (SD) unless stated otherwise. Numbers reported after covariates indicate number of measurements available when values were missing. ^a^Higher scores indicate better status. ^b^Lower scores indicate better status. ^c^When at least 10 Geriatric Depression Scale (GDS-15) questions were answered, missing data were imputed using the mean score of questions answered. ^d^Unable to read words printed in 5-mm capital letters, with or without glasses, at a normal reading distance. ^e^Using hearing aid and/or unable to hear a conversation held at usual speaking voice from a distance of 1 meter. SD, standard deviation.

Randomization {#sec0020}
-------------

Participants were randomized after completion of enrollment process and baseline assessment to ensure concealed allocation. Clusters (*n* = 36) of three to eight participants each (that lived in the same wing, unit, or floor) were formed. The randomization was stratified in all nursing homes except one, which only had a single cluster; an approach that aimed to have participants in both groups in each of the nursing homes and reduced the risk of factors associated with site to influence the outcome. Two researchers not involved in the study performed randomization by drawing lots using sealed opaque envelopes. The Regional Ethics Review Board in Umeå approved the study (2011-205-31M).

Intervention {#sec0025}
------------

The exercise and attention control activities were conducted at the nursing homes in small groups (*n* = 3--8), each supervised by two Physical Therapists (PT) and one Occupational Therapist (OT) or OT assistant. The intervention started October 2011 and lasted four months (40 sessions in total) and consisted of five 45-minute sessions per two-week period. When possible, supervised individual sessions were offered when participants were unable to attend a group session. While no activities were provided after the 4-month intervention, participation in activities other than provided by the study was not restricted at any time.

The exercise intervention was based on the High-Intensity Functional Exercise (HIFE) program, which includes a model for exercise selection and adefinition of exercise intensity, and is available from authors and described in detail elsewhere \[[@ref014]\]. The HIFE program comprises 39 functional exercises that aim to improve lower limb strength, balance, and mobility. Exercises are performed in weight-bearing positions, e.g., rising from a chair, stepping, and walking, and selected depending on individual degree of functional deficit. The intensity in muscle strengthening exercises was defined relative to repetition maximum (RM) \[[@ref032]\], i.e., "the maximal number of times a load can be lifted before fatigue using good form and technique" \[[@ref033]\]. The supervising PTs estimated RM in each exercise set, based on observation of participant response and performance. High exercise intensity was aimed for and defined as 8-12RM, thus progressed when able to exceed 12 repetitions \[[@ref030]\]. Strength exercises were progressed by adjustment of load, for example, by altering the step or seat height, or by adding weights to a weighted waist belt (maximum 12 kg). High-intensity balance exercises aimed to fully challenge postural stability, i.e., performed at or near the limit of maintaining an upright position \[[@ref030]\], and were progressed by, for example, narrowing the base of support or changing the support surface. Exercises were adapted throughout the intervention to meet participants' symptoms and changes in health and functional status. Participants were supervised individually to promote the highest possible exercise intensity. For safety, participants wore belts with handles so that PTs could provide support if needed when postural stability was fully challenged, thereby preventing falls. Unnecessary support was avoided. Participants were encouraged to exercise at moderate strength intensity (13--15RM) the first two weeks. At the end of each session leaders completed a structured protocol for each participant pertaining to adverse events and intensity achieved in muscle strength and balance exercises, which was estimated separately as high, moderate, or low according to the pre-defined scale \[[@ref031]\].

The attention control group participated in structured activities that were developed by the OTs and OT assistant that led the activities. The activities were structured around topics believed to be interesting for older people, including local wild life, seasons, and holidays. While seated in a group, participants conversed, sang, listened to music or readings, and/or looked at pictures and objects.

Outcome measures {#sec0030}
----------------

Trained research staff (PTs and physicians) performed all measurements. Baseline measurements were followed up on intervention completion at four months, and also at seven months to examine effects in the longer term. Testers were blinded to activity allocation and previous test results. The blinding was preserved throughout all cognitive tests by a pre-defined strategy to change tester if allocation was revealed. Global cognition was measured using the MMSE \[[@ref028]\] and the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) \[[@ref035]\], which have both been shown to have high test-retest reliability and be sensitive to change in people with mild to moderate dementia \[[@ref028]\], thus applicable to the present study's sample population. The ADAS-Cog was measured at baseline and at four months only. The MMSE (0--30) is an established measure of cognitive function, comprising 20 questions related to domains, e.g., attention, language, word recall, orientation to time and place, and where a higher score indicate better function. The ADAS-Cog (0--70) is measure of cognitive function widely used as an outcome measure in pharmaceutical trials targeting slowing progression of Alzheimer's disease, and was designed to improve assessment of subtle changes in symptoms \[[@ref036]\]. Similar to the MMSE, the ADAS-Cog measures various domains, but in contrast to the MMSE, a higher score indicates worse cognitive function. A minimal or maximal score was given on items on the MMSE or ADAS-Cog respectively when participants refused to answer, or when prevented by vision, hearing, or motor impairments.

Verbal fluency (VF) was used to measure executive function, and has been shown to have substantial test-retest reliability and be sensitive to change in people with dementia \[[@ref037]\]. Participants were asked to name as many animals as possible within one minute, and a higher number of animals named indicated better executive function. The rationale for choosing the VF test was its simple design, which is an advantage in populations that include participants with severe cognitive impairment to avoid missing values.

Descriptive measurements {#sec0035}
------------------------

Nutritional status was assessed using the Mini Nutritional Assessment (0--30) \[[@ref038]\]. Vision was considered impaired when unable to read a word printed in five-mm capital letters, with or without glasses, at normal reading distance. Self-reported health was evaluated using the first question from the Short-Form-36 Health Survey \[[@ref039]\]. Symptoms of depression were assessed using the 15-item Geriatric Depression Scale (0--15) \[[@ref040]\]; when≥10 questions were answered, missing data was imputed using the individual mean of questions answered. Electronic records of past medical history, which included brain imaging in most cases, current pharmaceutical treatment, and assessment results, were used to record dementia type, depressive disorders, and delirium diagnoses. A specialist in geriatric medicine reviewed and confirmed these diagnoses according to DSM-IV-TR criteria \[[@ref002]\].

Data analysis {#sec0040}
-------------

Sample size was calculated for the main outcome in the UMDEX study, the Barthel ADL Index \[[@ref014]\]. A sample size of 183 participants was required to verify significant intervention effects at a statistical power of 80% at the 4-month follow-up, a significance level of 0.05, two-sided, and a presumed dropout rate of 10%.

Baseline characteristics are presented as means (standard deviation) or frequencies (percentages). A comparison between exercise and attention control groups was performed using Student *t*-test or Pearson chi-squared test, and associations (*r*≥0.3) with changes in outcome measures at 4 and 7 months using Pearson correlation coefficient. While antidepressant use differed between groups (*p* = 0.04) and was adjusted for in analyses, no other variables differed between groups at baseline. No variable was found to associate with change in outcome measures above predefined levels.

In an intention-to-treat approach all available data for participants were analyzed according to original allocation and regardless of level of attendance. Linear mixed effects models were used to analyze longitudinal changes in MMSE and VF from baseline to 4 and 7 months, and in ADAS-Cog from baseline to 4 months, using interaction terms for activity and time point and adjustment for age, sex, and antidepressant use as fixed effects, and individual and cluster allocation as random effects. Baseline values for outcome measures were included in the dependent variable to avoid loss of data. The least square mean within-group difference was estimated from thesemodels.

Subgroup analyses were conducted according to dementia type and cognitive level by adding interaction terms to adjusted models. Dementia type was dichotomized into AD versus all other (non-Alzheimer's, non-AD) types of dementias \[[@ref014]\], in part to aid comparison of results with studies that include participants with AD only, and also since previous studies indicate that relevant differences between these two dementia subgroups may exist \[[@ref003]\]. Level of cognitive impairment was dichotomized based on the median MMSE score of 15, ADAS-Cog score of 30, and VF score of 6.

The influence of outliers was explored in sensitivity analyses by repeating adjusted analyses after removal of extreme values. The influence of level of adherence on exercise effects was explored by adding an interaction term. Level of adherence was dichotomized based on the median number of activity sessions attended, which was 32 of the 40 possible, and which also correlates with the twice weekly recommended dose of strength exercise in older people \[[@ref041]\].

All analyses were performed using IBM SPSS statistics for Macintosh version 23.0 (IBM Corp. Armonk, NY) and R version 3.2.2 (R Core Team, Vienna, Austria) software. All statistical tests were two tailed and *p* \< 0.05 was considered to be statistically significant.

Results {#sec0045}
=======

In total, 141 women and 45 men, with mean±standard deviation (SD) age of 85.1±7.1 y and a MMSE score of 14.9±3.5 were included ([Table 1](#jad-60-jad170014-t001){ref-type="table"}). Sixty-seven (36.0%) of participants had AD, 77 (41.4%) vascular dementia, and 15 (8.1%) mixed AD and vascular dementia. Twenty-seven (8.1%) participants had other types of dementia including 4 (2.2%) alcohol related, 1 (0.5%) dementia with Lewy bodies, 4 (2.2%) frontotemporal, 2 (1.1%) Parkinson's disease dementia, 6 (3.1%) mixed vascular and other types, and 10 (5.4%) had unspecified dementia. Over the 4-month intervention period, adherence in the exercise group was 73% and in the attention control group 70%. All adverse events recorded during exercise sessions were minor or temporary \[[@ref014]\]. Strength exercises were estimated to be performed at moderate intensity 40% and at high intensity 45% of attended sessions, and balance exercises at moderate intensity 27% and high intensity 63% of attended sessions.

Outcomes {#sec0050}
--------

There were no differences in mean change from baseline between exercise and activity groups (95% confidence intervals, CI) at 4 months in MMSE (--0.27; 95% CI --1.4 to 0.87, *p* = 0.644), ADAS-Cog (--1.04, 95% CI --4 to 1.92, *p* = 0.491), or VF (--0.53, 95% CI --1.42 to 0.35, *p* = 0.241) or 7 months in MMSE (--1.15, 95% CI --2.32 to 0.03, *p* = 0.056) or VF (--0.18, 95% CI --1.09 to 0.74, *p* = 0.707; [Table 2](#jad-60-jad170014-t002){ref-type="table"}, [Fig. 2](#jad-60-jad170014-g002){ref-type="fig"}).

###### 

Within- and between-group differences from baseline in the Mini-mental state examination (MMSE), the Verbal fluency test (VF), and the Alzheimer's disease assessment scale --cognitive section (ADAS-Cog)

                Within-group differences   Between-group differences                                                         
  ------------ -------------------------- --------------------------- ---- --------------- ------------------------- ------- ------
  MMSE                                                                                                                        0.11
    4 months               81                    --1.15 (0.41)         85   --0.93 (0.4)    --0.27 (--1.4 to 0.87)    0.644  
    7 months               75                    --2.25 (0.42)         76   --1.11 (0.42)   --1.15 (--2.32 to 0.03)   0.056  
  VF                                                                                                                          0.04
    4 months               80                    --0.74 (0.32)         81   --0.21 (0.32)   --0.53 (--1.42 to 0.35)   0.241  
    7 months               74                    --0.89 (0.33)         72   --0.71(0.33)    --0.18 (--1.09 to 0.74)   0.707  
  ADAS-Cog                                                                                                                    0.08
    4 months               84                     1.51 (1.06)          82    2.55 (1.07)     --1.04 (--4 to 1.92)     0.491  

Values are from linear mixed-effects models adjusted for age, sex, and antidepressant use. ^a^Based on proportion of variation explained by cluster. ICC, intracluster correlation coefficient; *n*, number of participants with complete data.

![Between-group differences from baseline in Mini-Mental State Examination (MMSE) and Verbal fluency (VF). Values are least square mean change from baseline, with 95% confidence intervals, from linear mixed-effects models adjusted for age, sex, and antidepressant use.](jad-60-jad170014-g002){#jad-60-jad170014-g002}

In interaction analyses, exercise effects on MMSE, VF, or ADAS-Cog did not differ according to sex or dementia type ([Supplementary Tables 1--2](#S1){ref-type="supplementary-material"}). In addition, the interaction analyses indicated that exercise effects on VF or ADAS-Cog did not differ according to cognitive level at baseline at any follow-up. While the exercise effects on MMSE did not differ according to cognitive level at the four-month follow-up, it differed at the seven-month follow, with a negative exercise effect in participants with lower cognitive function at baseline ([Supplementary Table 3](#S1){ref-type="supplementary-material"}).

In sensitivity analyses, when adjusted analyses were repeated after removal of extreme outliers at the 4-month follow-up (ADAS-Cog = 4, VF = 1), the intervention effects on cognitive function remained essentially the same (data not shown). Exercise effects on MMSE, VF, and ADAS-Cog did not differ according to level of adherence (data not shown).

Discussion {#sec0055}
==========

In this study of older people with dementia living in nursing homes, when compared with a control activity a 4-month, high-intensity functional exercise program did not result in significant differences in global cognitive or executive function. The exercise effects did not differ according to dementia type, sex, or cognitive level at baseline.

This result concurs with that of two large randomized controlled trials of people with dementia set in nursing homes and communities, respectively, and with multicomponent interventions (combinations of muscle strength, balance, walking, or other aerobic exercise) targeting functional improvement \[[@ref016]\]. In the studies, no exercise effects on global cognitive function were observed, neither in comparison with low-intensity exercise \[[@ref016]\] nor usual care \[[@ref018]\]. Although effects on cognitive function are conceivable through strength exercise, the absence of effects in the present study may be attributed to a limited aerobic component in the exercise program, as cardiovascular improvement in particular has been proposed to mediate effects on cognitive function \[[@ref010]\]. However, results of our study also agree with a large study of people with dementia in the community setting, where a four-month, moderate-to-high-intensity, aerobic exercise program had no effects on global cognitive function when compared with usual care in intention-to-treat analyses \[[@ref043]\], even though cardiorespiratory fitness was shown to improve \[[@ref044]\].

While knowledge regarding optimal exercise intensity, frequency, and duration for effects on cognitive function is still inconclusive \[[@ref009]\], participants may not have reached the minimal effective dose. Nevertheless, most participants exercised at a moderate-to-high intensity, and half attended at least twice per week, which is encouraging considering this population of older people with dementia living in nursing homes. Furthermore, for effects on cognitive function the duration of the exercise intervention may be critical, and the four-month intervention in our study was perhaps too short. Dependent on type of exercise and intensity, up to six to twelve-month interventions have been proposed for observable effects on brain structure \[[@ref009]\], and indeed some longer trials in people with dementia show positive effects \[[@ref018]\] though inferences are limited by methodological constraints. Furthermore, the observation of structural changes in the brain may not necessarily equal corresponding effects on cognitive function \[[@ref045]\], which may take even longer. In addition, it has been suggested that certain cognitive domains such as executive function may be particularly sensitive to effects of exercise \[[@ref009]\]. In people at risk of cognitive decline, the longest and largest trial to date found that while a two-year multicomponent exercise program had no effects on global cognitive function, subgroup effects on executive function was evident \[[@ref011]\]. However, the present study found no effects on either global or executive cognitive function, which perhaps was due to the shorter duration.

Our study indicated negative exercise effects on cognition that approached statistical significance in MMSE at the 7-month follow-up, particularly in participants with lower cognitive function at baseline. However, since 3 months had transpired since the end of the intervention, during which no activities were offered by the study, causal inferences are limited. Furthermore, the result was not substantiated in analyses on VF or ADAS-Cog in the present study.

We have previously reported beneficial effects of a high-intensity functional exercise program on balance and dependence ADLs in people with non-Alzheimer's type of dementia living in nursing homes \[[@ref014]\]. These results together with the results from the present study concur with that of a systematic review in people with dementia, which indicate that while exercise seems to improve ability to perform ADLs, there was no clear evidence of benefits on cognitive function \[[@ref013]\]. Despite the limited causal evidence that exercise affects cognitive function, the activity limitation in people with dementia may still be attenuated by physical exercise. Dependence in ADLs is influenced not only by cognitive function but also physical function. Exercise programs may improve gait and balance, and, therefore, dependence may also decline in ADLs \[[@ref013]\]. For this purpose, a 4-month, high-intensity functional exercise program seemseffective \[[@ref014]\].

Strengths of this study include the randomized design, a non-exercise attention control group, blinded assessors, and a comparison betweendementia types, all of which contribute to results that may be generalized to older people with dementia living in nursing homes. This study also has limitations. The ADAS-Cog was only tested at baseline and 4-month follow-up due to limited funding, which was unfortunate for comparison of effects between tests; however, all 3 cognitive tests indicated similar results at 4 months. Although baseline assessment of MMSE was conducted during the enrollment process, which was on average 1 month prior to the baseline assessments of ADAS-Cog and VF, the time difference did not differ between groups. Components of the attention control activity may resemble cognitive stimulation, i.e., engagement in activities that provide stimulation for thinking, concentration, and memory, with the aim to improve cognitive and social function \[[@ref046]\]. The control activities in the present study did not aim to enhance cognitive function; however, a certain effect cannot be ruled out. While it would have been interesting to analyze exercise effects more closely based on dementia type, this was prevented by concerns regarding power. Although the etiology in the non-AD group varied, which may affect the implication of these results, 82% had a vascular type of dementia, either alone or in combination with other types of dementia. The sample size was comparatively large, yet based on power calculations on a different outcome; subgroup analyses may still have limited power and should be interpreted withcaution.

Conclusion {#sec0060}
----------

A 4-month, high-intensity functional exercise program had no superior effects on global cognition or executive function in people with dementia living in nursing homes when compared with an attention control activity, notwithstanding dementia type, sex, or cognitive level at baseline.
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###### Supplementary Tables

###### 

Click here for additional data file.
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